JY
HCAT icon

Jeff Yass’s Health Catalyst HCAT Stock Holding History

Jeff Yass’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Buy
437,227
+356,073
+439% +$514K ﹤0.01% 8554
2026
Q1 		$103K Buy
81,154
+53,830
+197% +$101K ﹤0.01% 12321
2025
Q4 		$65.3K Sell
27,324
-17,004
-38% -$46.5K ﹤0.01% 11656
2025
Q3 		$126K Sell
44,328
-110,855
-71% -$379K ﹤0.01% 11411
2025
Q2 		$585K Buy
155,183
+49,559
+47% +$195K ﹤0.01% 8813
2025
Q1 		$478K Buy
105,624
+2,174
+2% +$11.5K ﹤0.01% 8991
2024
Q4 		$731K Sell
103,450
-30,923
-23% -$246K ﹤0.01% 7719
2024
Q3 		$1.09M Buy
134,373
+102,125
+317% +$738K ﹤0.01% 6583
2024
Q2 		$206K Sell
32,248
-17,392
-35% -$112K ﹤0.01% 10295
2024
Q1 		$374K Buy
49,640
+7,963
+19% +$72.7K ﹤0.01% 9186
2023
Q4 		$386K Buy
41,677
+189
+0.5% +$1.54K ﹤0.01% 9271
2023
Q3 		$420K Sell
41,488
-35,192
-46% -$420K ﹤0.01% 8638
2023
Q2 		$959K Buy
76,680
+21,529
+39% +$256K ﹤0.01% 6774
2023
Q1 		$644K Buy
55,151
+30,325
+122% +$387K ﹤0.01% 7954
2022
Q4 		$264K Sell
24,826
-50,414
-67% -$487K ﹤0.01% 9418
2022
Q3 		$730K Buy
+75,240
New +$996K ﹤0.01% 7455
2022
Q1 		– Sell
-18,397
Closed -$522K – 13396
2021
Q4 		$729K Buy
18,397
+10,460
+132% +$477K ﹤0.01% 8138
2021
Q3 		$397K Buy
+7,937
New +$433K ﹤0.01% 9956
2021
Q1 		– Sell
-6,958
Closed -$337K – 12463
2020
Q4 		$303K Sell
6,958
-2,293
-25% -$84.6K ﹤0.01% 9227
2020
Q3 		$339K Sell
9,251
-17,725
-66% -$602K ﹤0.01% 8465
2020
Q2 		$787K Buy
26,976
+14,385
+114% +$398K ﹤0.01% 6427
2020
Q1 		$329K Buy
+12,591
New +$385K ﹤0.01% 7801

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HCAT Position: Q2 2026 in Review

Jeff Yass increased its Health Catalyst (HCAT) stake by 439% in Q2 2026, buying an estimated $514K and bringing the position to 437,227 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #8554.

Jeff Yass first reported a position in HCAT in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.09M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Jeff Yass held 437,227 shares of Health Catalyst worth $870K as of Q2 2026.
  • Jeff Yass bought 356,073 Health Catalyst shares in Q2 2026, an estimated $514K.
  • Health Catalyst made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8554 holding.
  • Jeff Yass first reported a position in Health Catalyst in Q1 2020 and has held it in 22 quarters since.
  • Jeff Yass's Health Catalyst position peaked at $1.09M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.